Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pet Imaging as a Biomarker of Everolimus Added Value in Hormone Refractory postmenopausaL Women

NCT02028364 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT02028364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02028364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pet Imaging as a Biomarker of Everolimus Added Value in Hormone Refractory postmenopausaL Women
Lead sponsor
Jules Bordet Institute
Phase
Phase 2
Overall status
Completed
Start date
January 12, 2014
Completion date
August 9, 2021
Enrollment
55 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer